0001375151-19-000026.txt : 20190315 0001375151-19-000026.hdr.sgml : 20190315 20190315172140 ACCESSION NUMBER: 0001375151-19-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190313 FILED AS OF DATE: 20190315 DATE AS OF CHANGE: 20190315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAWLEY ROGER CENTRAL INDEX KEY: 0001257386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 19686001 MAIL ADDRESS: STREET 1: 3655 NOBEL DRIVE, SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_155268488209948.xml FORM 4 X0306 4 2019-03-13 0 0001375151 ZOGENIX, INC. ZGNX 0001257386 HAWLEY ROGER C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2019-03-13 4 S 0 21211 53.0958 D 49364 D Common Stock 2019-03-14 4 S 0 38789 52.9341 D 10575 D The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $53.00 to $53.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $52.7692 to $53.3050, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Thomas Doyle, Attorney-in-fact for Roger Hawley 2019-03-15